U.S. Infrastructure Stock News

Nebius Group N.V. reported first-quarter 2026 results showing sales rising to US$399 million from US$50.9 million a year earlier and a swing from a US$113.5 million net loss to US$621.2 million in net income. Around the same time, Nebius signed a long-term fuel cell capacity agreement with Bloom Energy to secure cleaner, behind-the-meter power for its expanding AI data centers, directly addressing one of the biggest bottlenecks in scaling AI infrastructure: reliable electricity supply. We’ll...

Recent performance snapshot Kilroy Realty (KRC) has drawn investor attention after a mixed return profile, with the stock up over the past month and past 3 months, but down year to date. Over the past month, Kilroy Realty has gained about 7%, adding to a roughly 6% rise over the past 3 months, while the stock remains about 10% lower year to date. See our latest analysis for Kilroy Realty. At a share price of $34.14, Kilroy Realty’s recent 7.3% 1 month share price return contrasts with a year...

WesBanco (WSBC) has given investors fresh news to consider by expanding its stock repurchase authorization by 4.0 million shares and declaring quarterly dividends for both common and preferred shareholders. See our latest analysis for WesBanco. At a share price of $34.62, WesBanco has seen short term momentum soften, with a 30 day share price return of 3.11% and a 90 day decline of 6.05%. At the same time, a 1 year total shareholder return of 18.73% and a 3 year total shareholder return of...

Lululemon athletica (NasdaqGS:LULU) is in an escalating proxy battle between its board and founder Chip Wilson, with both sides issuing public statements and filing proxy materials. Competing director slates are set for a high stakes shareholder vote on June 25, focused on control over the company’s creative direction and future strategy. Elliott Investment Management and other investors have taken positions in expectation of substantial corporate change, intensifying scrutiny of board...

Costco Wholesale (COST) is back in focus after lifting its quarterly dividend by 13% for the 22nd straight year, supported by double digit comparable sales growth and membership renewal rates above 89%. See our latest analysis for Costco Wholesale. The stock has eased roughly 2% over the past day but still carries a 7 day share price return of 0.9% and a year to date share price return of 22.9%. The 5 year total shareholder return of 186.1% signals strong long term momentum. If Costco’s mix...

Lam Research (LRCX) sits at the center of the semiconductor equipment market, and its recent share performance has drawn attention as investors weigh reported returns against the company’s current revenue and profit profile. See our latest analysis for Lam Research. Over the past year, Lam Research has seen strong momentum, with the share price at US$302.24 following a 1-day share price return of 3.48% and a 30-day share price return of 16.98%. The 1-year total shareholder return of 268.77%...

Recently, Sprouts Farmers Market added former Apollo Global Management partner Andrew Jhawar back to its board and became Elmhurst 1925’s first national retail partner for the Clean Protein plant-based beverage line, now available across Sprouts stores in the US. These governance and product moves highlight Sprouts’ focus on experienced leadership and differentiated, clean-label offerings in the growing plant-based protein category. Next, we’ll examine how Jhawar’s return to the board could...

What recent performance says about FormFactor stock FormFactor (FORM) has drawn attention after a mixed stretch for the stock, with a gain of about 35% over the past 3 months but a decline of roughly 10% over the past month. See our latest analysis for FormFactor. That mix of a roughly 10% decline in the 1 month share price return, alongside a 35.36% 3 month share price return, suggests momentum has cooled recently. At the same time, the longer term trend, including a very large 1 year total...

Recent performance snapshot Agnico Eagle Mines (NYSE:AEM) has drawn investor attention after a period in which the stock fell about 12% over the past month and about 22% over the past 3 months, against a backdrop of mixed return signals. See our latest analysis for Agnico Eagle Mines. The recent slide, including a 7 day share price return of down 7.74% and a 3 month share price return of down 22.13%, contrasts sharply with Agnico Eagle Mines' 1 year total shareholder return of 56.72%. This...

In recent months, multiple law firms, including Pomerantz LLP and Bernstein Liebhard LLP, have filed securities class action lawsuits against Coty Inc., alleging that the company and certain former officers misled investors about growth prospects, margins, and the health of its Consumer Beauty and Prestige fragrance businesses during 2025 and early 2026. The lawsuits center on claims that Coty’s upbeat guidance and commentary conflicted with internal signs of slowing growth, compressed...

MARA Holdings, Inc. has already reported first-quarter 2026 results showing sales of US$174.61 million versus US$213.88 million a year earlier and a net loss of US$1.26 billion versus US$533.20 million, while outlining a US$1.52 billion deal to acquire Long Ridge Energy & Power and expand into energy-backed AI infrastructure. These developments coincide with US President Donald Trump disclosing a personal equity stake in MARA Holdings, an unprecedented move that links the company’s bitcoin...

Viavi Solutions (NasdaqGS:VIAV) has announced and priced a US$500 million follow on equity offering. The company plans to use the proceeds to repay debt and for general working capital. The transaction represents a significant capital raise relative to the company and marks a material update to its capital structure. Viavi Solutions operates in communications test, measurement, and optical technologies, serving network operators and related customers. For investors, the fresh equity raise...

Nuvalent plans to present pivotal clinical trial data at the 2026 ASCO Annual Meeting. The presentations include neladalkib data in ALK-positive NSCLC that supported a recent FDA NDA submission and an ongoing Phase 3 trial. The company will also share the first clinical look at zidesamtinib in ROS1-positive solid tumors, including early response data. Nuvalent (NasdaqGS:NUVL) is drawing attention ahead of ASCO 2026 as it prepares to showcase data that underpin a recent FDA NDA filing for...

Tapestry (TPR) has just secured a U.S. patent for Mira, its in house AI platform built to connect data across the business and support faster decisions around inventory, assortments and consumer trends. See our latest analysis for Tapestry. The patent news lands as Tapestry’s share price, now at US$139.11, reflects mixed momentum, with a 7 day share price return of 6.81% and a 30 day return that fell 7.57%, while the 1 year total shareholder return of 78.66% points to a strong longer term...

Why Halozyme Therapeutics (HALO) Is Drawing Investor Attention Now Halozyme Therapeutics (HALO) is back on investors’ radar after a period of mixed share performance, with the stock roughly flat over the past month but lower over the past 3 months. See our latest analysis for Halozyme Therapeutics. At around US$68.52, Halozyme’s recent share price moves have been relatively muted, yet the 1 year total shareholder return of 27.48% and 3 year total shareholder return of 106.76% point to longer...

Most biotech stocks working towards a treatment for Parkinson's are already carrying a premium price. These three sit further off the radar, and analysts think the market has them badly wrong.

Stock performance snapshot Manhattan Associates (MANH) has been drawing attention after a mixed run in recent months, with the stock down about 20% year to date and roughly 28% over the past year. Short term performance looks different. The share price eased around 1.8% in the latest session but rose about 4.3% over the past week and has held close to flat over the past month. Over longer periods the picture has been weaker, with total returns declining about 23% over three years and roughly...

Hanover Insurance Group (NYSE:THG) has appointed Patricia A. Norton-Gatto as Principal Accounting Officer. The appointment reflects an internal promotion following Ms. Norton-Gatto’s long tenure and progression within the company. This move affects oversight of the company’s financial reporting and accounting functions, areas closely watched by many investors. For you as an investor, this change sits at the core of how Hanover Insurance Group presents its financial picture. As a property...

Earlier this month, American Homes 4 Rent declared a US$0.33 per share cash dividend on its common stock for the second quarter of 2026, alongside quarterly cash distributions of US$0.36719 per share on its 5.875% Series G and US$0.39063 per share on its 6.250% Series H cumulative redeemable perpetual preferred shares, all payable on June 30, 2026 to shareholders of record on June 15, 2026. These dividend declarations, coming shortly before a broker rating upgrade, highlight how income...

Dover’s Microwave Products Group plans to launch three AI-enabled RF and electronic warfare solutions for Aerospace & Defense at AOC Europe 2026. The new products focus on radio frequency signal identification and electronic warfare capabilities for defense and aerospace customers. The launches expand Dover’s presence in advanced RF and signals intelligence technologies within a key end market. For investors tracking NYSE:DOV, these product launches come as the stock trades at $207.77, with...

Walmart (WMT) opened its Q1 2027 reporting season with investors still focused on its recent run of quarterly results, which saw Q4 2026 revenue at about US$190.7b, basic EPS of US$0.53 and net income of US$4.2b. Over the last year, quarterly revenue moved from roughly US$165.6b in Q1 2026 to US$190.7b in Q4 2026, while basic EPS ranged between US$0.53 and US$0.88 as the retailer cycled through different trading periods. With trailing 12 month earnings growth of 12.6% and profit margins...

BeOne Medicines' BCL-2 inhibitor sonrotoclax (BEQALZI) has received accelerated FDA approval for relapsed or refractory mantle cell lymphoma. The decision marks a key regulatory milestone in hematology oncology for patients whose disease persists or returns after prior treatment. Sonrotoclax is also under review in additional regions and indications across hematologic malignancies. BeOne Medicines, listed as NasdaqGS:ONC, focuses on targeted therapies in hematology oncology, an area where...

In May 2026, Microchip Technology reported strong fiscal Q4 and full-year 2026 results, beating prior earnings guidance, tightening inventory, and returning US$984 million to shareholders via dividends while guiding to higher sales and margins for Q1 2027. Alongside these results, Microchip launched its EX-423 evacuated miniature crystal oscillator for high-reliability markets, underscoring how niche, ruggedized timing products may broaden its reach in defense, communications, and industrial...

If you are wondering whether Booking Holdings at around US$159.68 is starting to look attractively priced or still has further to fall, the valuation picture is the key piece to focus on next. The stock has risen about 3.4% over the past week, but is still down around 16.3% over the past month, about 25.0% year to date, and about 24.7% over the last year, set against much stronger gains of 56.6% over three years and 74.2% over five years. Recent moves have come as investors reassess the...